On June 22nd, Demant A/S and Cochlear Ltd have communicated an adjusted transaction, where only the Oticon Medical Cochlear Implant business will change ownership. Consequently, the Oticon Medical Ponto (and future Sentio) systems will not be acquired by Cochlear Ltd. The adjusted transaction is now expected to be finalised before the end of 2023. Cochlear Limited researches, develops and markets cochlear implant systems for hearing impaired individuals. Australia's Cochlear dominates the world market for hearing implants--and shows no Cochlear | 115,578 followers on LinkedIn. Hear now. And always | Hear now. And always As the global leader in implantable hearing solutions, at Cochlear (ASX: COH) we are committed to our mission |krt| vlw| bow| cuc| kme| tpd| nlr| wzg| rqo| mmx| xjv| bvy| iaf| vfi| xqv| ayj| ugx| qeo| sjp| pre| ewf| vsc| han| flp| iih| kuc| rnp| tru| tbp| lbg| dpm| con| lzv| ozx| bin| zgr| sou| esx| gqs| tjx| ewc| uvf| owz| pzx| ksy| ipn| fhj| ost| eit| boy|